Headquarters: Vancouver, British Columbia, Canada
Industry: Early Drug Development
Investors Number: 6.0
Funding Status: Early Stage Venture
Last Funding Type: Series A
Founded Date: 2021-01-01
Total Funding: 40000000.0
Last Funding Date: 2022-01-31